EUVIMEDEUVIMED entdecken
Crossref

Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification

Shan Jiang iD, Gesine Eis-Janzyk, Ruben Augustin iD, Holger Kleinertz iD, Saskia Schröder iD, Jan Sevecke iD, Weixin Xie iD, Haoyan Pan iD, Isabell Behrens iD, Samira Weisselberg iD, Lilly-Charlotte Albertsen iD, Elena Müller iD und 11 weitere

Science Translational Medicine · 06.05.2026 · 18 (848)

DOI: 10.1126/scitranslmed.ady4761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 06.05.2026. Verfasst von Shan Jiang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma and Orthopedic Surgery, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany. Hauptthemen laut MEDLINE: Ossification, Heterotopic, Extracellular Traps, Myeloid Cells, Wounds and Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After musculoskeletal injury, a considerable proportion of patients develop heterotopic ossification (HO), the formation of bone at ectopic sites. Traumatic HO is a disabling condition, potentially resulting in loss of joint function and compression of neurovascular structures. Available treatment options are often unsuccessful, frequently necessitating surgical resection of HO lesions with a high risk of recurrence. Given that myeloid cells, including neutrophils and macrophages, are among the first cell types to infiltrate injured tissue, the present study explored the relationship of extracellular traps (ETs) with HO formation in humans and mice. Human HO sample analysis revealed the presence of different stages of ETosis, which are clinically associated with increased ET concentrations in the blood. Experimentally, genetic impairment of ET resolution through combined DNase1 and DNase1l3 deficiency led to increased traumatic HO in mice, whereas HO was strongly attenuated by additional deletion of the ET generator Padi4 . Neutrophil depletion impaired local ET formation, reduced HO formation, and blunted genotype-specific differences in HO outcome. In osteogenic precursors, ETs promoted matrix mineralization, and inhibition of ETosis or degradation of cell-free DNA, a major ET component, resulted in reduced osteogenesis. Pharmacological facilitation of ET clearance by dornase alfa, a US Food and Drug Administration–approved recombinant DNase1, or inhibition of ETs by the PADI4 inhibitor GSK484, resulted in inhibition of traumatic HO formation in mice without adversely affecting systemic bone remodeling. Together, our clinical and experimental findings demonstrate that traumatic HO is mediated by targetable neutrophil-dependent mechanisms, with altered ET formation contributing to these effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ossification, HeterotopicExtracellular TrapsMyeloid CellsWounds and InjuriesAnimalsHumansNeutrophilsProtein-Arginine Deiminase Type 4Deoxyribonuclease IMiceMaleMice, Inbred C57BLOsteogenesis

Substanzen

Protein-Arginine Deiminase Type 4Deoxyribonuclease Ipeptidylarginine deiminase 4, mouse

Autor:innen und Institutionen

  • Department of Trauma and Orthopedic Surgery, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Institute of Immunology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Center for Thrombosis and Hemostasis (CTH), Johannes Gutenberg University Medical Center, 55131 Mainz, Germany.
  • Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.

ORCID-Profile: Shan Jiang, Ruben Augustin, Holger Kleinertz, Saskia Schröder, Jan Sevecke, Weixin Xie, Haoyan Pan, Isabell Behrens, Samira Weisselberg, Lilly-Charlotte Albertsen, Elena Müller, Simon von Kroge, Assil-Ramin Alimy, Michael Amling, Eva Tolosa, Thomas Renné, Konrad Mader, Tim Rolvien, Anke Baranowsky, Johannes Keller

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Jiang, S., Eis-Janzyk, G., Augustin, R., Kleinertz, H., Schröder, S., Sevecke, J., Xie, W., Pan, H., Behrens, I., Weisselberg, S., Albertsen, L. C., Müller, E., von Kroge, S., Alimy, A. R., Fal, M., Amling, M., Tolosa, E., Renné, T., Frosch, K. H., …, & Keller, J. (2026). Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification. Science Translational Medicine, 18(848). https://doi.org/10.1126/scitranslmed.ady4761

Vancouver

Jiang S, Eis-Janzyk G, Augustin R, Kleinertz H, Schröder S, Sevecke J, et al. Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification. Science Translational Medicine. 2026;18(848). doi:10.1126/scitranslmed.ady4761

BibTeX
@article{Jiang2026,
  author = {Jiang, Shan and Eis-Janzyk, Gesine and Augustin, Ruben and Kleinertz, Holger and Schröder, Saskia and Sevecke, Jan and Xie, Weixin and Pan, Haoyan and Behrens, Isabell and Weisselberg, Samira and Albertsen, Lilly-Charlotte and Müller, Elena and von Kroge, Simon and Alimy, Assil-Ramin and Fal, Milad and Amling, Michael and Tolosa, Eva and Renné, Thomas and Frosch, Karl-Heinz and Mader, Konrad and Rolvien, Tim and Baranowsky, Anke and Keller, Johannes},
  title = {Extracellular traps from myeloid cells as therapeutic targets in traumatic heterotopic ossification},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {848},
  doi = {10.1126/scitranslmed.ady4761}
}
Kostenlos starten →